Trinity beats St. Ignatius for third time to win 4A Argo Regional

SHARE Trinity beats St. Ignatius for third time to win 4A Argo Regional

After seeing its streak of 10 consecutive regional titles come to an end last year, second-seeded Trinity showed no signs of letdown with a 49-33 victory over seventh-seeded St. Ignatius (17-12) Thursday night in the 4A Argo Regional final.

DePaul-bound guard Lauren Prochaska led Trinity (24-5) with 15 points, as the Blazers held their GCAC Red rivals to 3-of-14 shooting in the second and third quarters. Trinity scored 10 consecutive points to take a 39-18 lead with 2:24 remaining in the third quarter.

Annie McKenna scored 14 points for Trinity and Kaitlin Aylward contributed 12.

“We definitely didn’t want a repeat of last year,” Prochaska said. “We don’t take anyone lightly or for granted. We are taking it one game at a time.”

St. Ignatius senior Gabby Diamond scored a team-high 10 points and her pair of 3-pointers were the Wolfpack’s only baskets in the third quarter.

Trinity took a 21-11 lead at halftime with a defensive effort that held St. Ignatius to one basket for nearly 10 minutes in the first half.

Prochaska and Aylward combined 14 points in the first half to outscore St. Ignatius’ entire team.

The Blazers will play third-seeded Kenwood, a 69-55 winner over Riverside-Brookfield, at 8 p.m. Tuesday in the Hinsdale South Sectional semifinal.

The Latest
Girls says the man is angry that she stood up for her mom in a disagreement about the couple’s sex and drinking habits.
Parent company Global Tetrahedron has big plans to diversify the satire news website’s revenue streams and bring back a print edition
Trout Unlimited’s Trout In The Classroom teaches young students about fish and the aquatic environment, capped by a day trip to get all wet.
From endorsing a new Bears’ stadium to revoking the subminimum wage, Johnson’s critics and allies examine where he and the city are going.
High doses become routine patient care even when they make patients so ill that they skip doses or stop taking the drugs. “There’s a gap in FDA’s authority that results in patients getting excess doses of a drug at excess costs,” says Dr. Mark Ratain.